Page last updated: 2024-11-05

ici 204,219 and Hepatitis D

ici 204,219 has been researched along with Hepatitis D in 1 studies

zafirlukast: a leukotriene D4 receptor antagonist

Hepatitis D: INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donkers, JM1
Zehnder, B1
van Westen, GJP1
Kwakkenbos, MJ1
IJzerman, AP1
Oude Elferink, RPJ1
Beuers, U1
Urban, S1
van de Graaf, SFJ1

Other Studies

1 other study available for ici 204,219 and Hepatitis D

ArticleYear
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.
    Scientific reports, 2017, 11-10, Volume: 7, Issue:1

    Topics: Animals; Antiviral Agents; Dogs; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus;

2017